{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:36Z","timestamp":1791839856567,"version":"4.3.4"},"reference-count":100,"publisher":"SAGE Publications","issue":"4_suppl","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Cosmetic Ingredient Review"},{"name":"Personal Care Products Council"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of Salicylic Acid and 17 salicylates; 15 of these ingredients were previously reviewed by the Panel, and 3 are reviewed herein for the first time. Some of the reported functions in cosmetics for ingredients in this group are hair and skin conditioning agents, and, less frequently, preservatives and fragrance ingredients. Upon review of relevant new data, including frequency and concentration of use, and consideration of data from the previous CIR report, the Panel concluded that these ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA).<\/jats:p>","DOI":"10.1177\/10915818251389456","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:13:11Z","timestamp":1763356391000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Amended Safety Assessment of Salicylic Acid and Salicylates as Used in Cosmetics"],"prefix":"10.1177","volume":"44","author":[{"suffix":"Jr","given":"Wilbur","family":"Johnson","sequence":"first","affiliation":[{"name":"Cosmetic Ingredient Review Former Senior Scientific Analyst\/Writer"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Toxicologist"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma F.","family":"Bergfeld","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald V.","family":"Belsito","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Hill","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Klaassen","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Liebler","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James G.","family":"Marks","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Shank","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Slaga","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monice M.","family":"Fiume","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Senior Director"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Heldreth","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Executive Director"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"issue":"3","key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/742241409","article-title":"Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate","volume":"22","author":"Cosmetic Ingredient Review Expert Panel","year":"2003","unstructured":"Cosmetic Ingredient Review Expert Panel. Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate. Int J Toxicol. 2003;22(3):1-108.","journal-title":"Int J Toxicol"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/1091581815596439"},{"key":"e_1_3_3_4_2","volume-title":"International Cosmetic Ingredient Dictionary and Handbook Online Version (wINCI)","author":"Nikitakis J","unstructured":"Nikitakis J, Lange B. International Cosmetic Ingredient Dictionary and Handbook Online Version (wINCI). Washington, DC. https:\/\/webdictionary.personalcarecouncil.org\/jsp\/Home.jsp. Last Updated 2018. Accessed March 6, 2017."},{"key":"e_1_3_3_5_2","unstructured":"Scientific Committee on Consumer Safety (SCCS). Opinion on salicylic acid (CAS 69-72-7). Submission 1. Adopted by written procedure on December 21 2018. https:\/\/ec.europa.eu\/health\/sites\/health\/files\/scientific_committees\/consumer_safety\/docs\/sccs_o_223.pdf. Last Updated 2018. Accessed January 7 2019."},{"key":"e_1_3_3_6_2","unstructured":"Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers (SCCNFP). Opinion of the scientific committee on cosmetic products and non-food products intended for consumers. https:\/\/ec.europa.eu\/health\/archive\/ph_risk\/committees\/sccp\/documents\/out170_en.pdf. Last Updated 2002. Accessed October 10 2018."},{"key":"e_1_3_3_7_2","unstructured":"The Metabolomics Innovation Center (TMIC). Metabocard for salicin (HMDB0003546). https:\/\/www.hmdb.ca\/metabolites\/HMDB0003546. Last Updated 2019. Accessed March 11 2019."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2007.09.041"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2007.09.045"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2007.09.053"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"PerkinElmer informatics. ChemDraw\u00ae 17; 2017.","DOI":"10.17323\/1998-0663.2017.2.17.24."},{"key":"e_1_3_3_12_2","unstructured":"Advanced Chemistry Development Labs (ACD Labs). Properties estimated using ACD labs software. V11.02. 2019."},{"key":"e_1_3_3_13_2","unstructured":"Chemical Abstracts Service (CAS). Scifinder\u00ae. Substance identifier: key properties of Salicylic Acid Hexyldodecyl Salicylic Acid Sodium Salicylate Tridecyl Salicylate and Amyl Salicylate. https:\/\/www.cas.org. Last Updated 2019. Accessed January 7 2019."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja01276a502"},{"issue":"7","key":"e_1_3_3_15_2","first-page":"29","article-title":"Synthesis of n-amyl salicylate catalyzed by sodium hydrogen sulfate","volume":"26","author":"Hua Y","year":"2009","unstructured":"Hua Y, Rong-xuan MA. Synthesis of n-amyl salicylate catalyzed by sodium hydrogen sulfate. Hua Xue Yu Sheng Wu Gong Cheng. 2009;26(7):29-31.","journal-title":"Hua Xue Yu Sheng Wu Gong Cheng"},{"key":"e_1_3_3_16_2","volume-title":"The United States Pharmacopoeia (USP)","author":"United States Pharmacopoeial Convention","year":"2009","unstructured":"United States Pharmacopoeial Convention. The United States Pharmacopoeia (USP). 32nd ed. Rockville, Maryland: The United States Pharmacopoeial Convention; 2009.","edition":"32"},{"key":"e_1_3_3_17_2","volume-title":"The National Formulary (NF)","author":"United States Pharmacopoeial Convention","year":"2009","unstructured":"United States Pharmacopoeial Convention. The National Formulary (NF). 27th ed. Rockville, Maryland: The United States Pharmacopoeial Convention; 2009.","edition":"27"},{"key":"e_1_3_3_18_2","volume-title":"Voluntary Cosmetic Registration Program - Frequency of Use of Cosmetic Ingredients","author":"U.S. Food and Drug Administration Center for Food Safety & Applied Nutrition (CFSAN)","year":"2019","unstructured":"U.S. Food and Drug Administration Center for Food Safety & Applied Nutrition (CFSAN). Voluntary Cosmetic Registration Program - Frequency of Use of Cosmetic Ingredients. College Park, MD; 2019."},{"key":"e_1_3_3_19_2","unstructured":"Personal Care Products Council. Concentration of use by FDA product category: salicylates. Unpublished data submitted by the Personal Care Products Council on 6-11-2018; 2018. pp. 1-5."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2011.05.1038"},{"key":"e_1_3_3_21_2","unstructured":"Bremmer HJ Prud'homme de Lodder LCH van Engelen JGM. Cosmetics fact sheet: to assess the risks for the consumer. Report No. RIVM 320104001\/2006. Updated version for ConsExpo 4. 20200 pp. 1-77. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/320104001.pdf. Accessed August 24 2011."},{"key":"e_1_3_3_22_2","unstructured":"Rothe H. Special aspects of cosmetic spray evaluation. Unpublished information presented to the 26 September CIR Expert Panel. Washington D.C.; 2011."},{"issue":"11","key":"e_1_3_3_23_2","first-page":"24","article-title":"The influence of particle size","volume":"14","author":"Johnsen MA","year":"2004","unstructured":"Johnsen MA. The influence of particle size. Spray Technol Mark. 2004;14(11):24-27. https:\/\/www.spraytechnology.com\/index.mv?screen=backissues","journal-title":"Spray Technol Mark"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.1979.tb00212.x"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0015-6264(79)90208-6"},{"key":"e_1_3_3_26_2","unstructured":"CIR Science and Support Committee of the Personal Care Products Council (CIR SSC). Cosmetic Powder Exposure; 2015."},{"key":"e_1_3_3_27_2","unstructured":"European Commission. CosIng database; following cosmetic regulation No. 1223\/2009. https:\/\/ec.europa.eu\/growth\/tools-databases\/cosing\/. Last Updated 2018. Accessed October 24 2018."},{"key":"e_1_3_3_28_2","unstructured":"International Fragrance Association (IFRA). Sandards library. Hexyl salicylate limits in the finished product (%). https:\/\/www.ifraorg.org\/en-us\/standards-library. Last Updated 2007. Accessed November 30 2018."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2006.08.009"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2014.10.005"},{"key":"e_1_3_3_31_2","article-title":"Registration, evaluation, authorization, and restriction of chemical substances (REACH) dossier","author":"European Chemicals Agency (ECHA)","unstructured":"European Chemicals Agency (ECHA). Registration, evaluation, authorization, and restriction of chemical substances (REACH) dossier. Ethylhexyl Salicylate. https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/14203. Last Updated 2018. Accessed October 25, 2018.","journal-title":"Ethylhexyl Salicylate"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068291"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018834021066"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/15287390600870874"},{"key":"e_1_3_3_35_2","first-page":"151","article-title":"Use of methyl salicylate as a stimulant to predict the percutaneous absorption of sulfur mustard","volume":"54","author":"Riviere JE","year":"2000","unstructured":"Riviere JE, Smith CE, Budsaba K, et al. Use of methyl salicylate as a stimulant to predict the percutaneous absorption of sulfur mustard. Toxicologist. 2000;54:151-152.","journal-title":"Toxicologist"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.718"},{"key":"e_1_3_3_37_2","first-page":"302","article-title":"Percutaneous penetration and metabolism of salicylic acid derivatives across hairless mouse skin in diffusion cell in vitro","volume":"5","author":"Higo N","year":"1995","unstructured":"Higo N, Sato S, Irie T, Uekama K. Percutaneous penetration and metabolism of salicylic acid derivatives across hairless mouse skin in diffusion cell in vitro. STP Pharma Sci. 1995;5:302-308.","journal-title":"STP Pharma Sci"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.838"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62032-6"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004268409"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.1992.tb00059.x"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.013029"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120022002"},{"key":"e_1_3_3_44_2","unstructured":"European Chemicals Agency (ECHA). Registration evaluation authorization and restriction of chemical substances (REACH) dossier. Sodium salicylate. https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/13593. Last Updated 2018. Accessed October 26 2018."},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2504\/kds.38.1064"},{"key":"e_1_3_3_46_2","first-page":"476","article-title":"Hindlimb metabolism in dogs intoxicated with methyl salicylate","volume":"48","author":"Ojiambo HP","year":"1972","unstructured":"Ojiambo HP. Hindlimb metabolism in dogs intoxicated with methyl salicylate. East Afr Med J. 1972;48:476-481.","journal-title":"East Afr Med J"},{"key":"e_1_3_3_47_2","unstructured":"European Chemicals Agency (ECHA). Registration evaluation authorization and restriction of chemical substances (REACH) dossier. Methyl salicylate. https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/2227. Last Updated 2018. Accessed October 27 2018."},{"key":"e_1_3_3_48_2","unstructured":"European Chemicals Agency (ECHA). Registration evaluation and authorization of chemicals (REACH) dossier. 2-hydroxybenzoic acid 2-butyloctyl ester (Butyloctyl Salicylate). https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/25791. Last Updated 2018. Accessed October 25 2018."},{"key":"e_1_3_3_49_2","unstructured":"National Toxicology Program (NTP). Methyl salicylate: reproduction and fertility assessment in CD-1 mice when administered by gavage. NTP-84-156; PB84-241140; 1984."},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(99)00179-4"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/15376510802355349"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(00)00023-0"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1263(200005\/06)20:3<205::AID-JAT635>3.0.CO;2-G"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2004.12.014"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.11.012"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.03.018"},{"issue":"7","key":"e_1_3_3_57_2","first-page":"830","article-title":"Safety of topical dermatologic medications in pregnancy","volume":"15","author":"Patel VM","year":"2016","unstructured":"Patel VM, Schwartz RA, Clark LW. Safety of topical dermatologic medications in pregnancy. J Drugs Dermatol JDD. 2016;15(7):830-834.","journal-title":"J Drugs Dermatol JDD"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21109"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac00107a022"},{"key":"e_1_3_3_60_2","volume-title":"Textbook of Clinical Chemistry","author":"Tietz NW","year":"1986","unstructured":"Tietz NW. Textbook of Clinical Chemistry. Philadelphia: W.B.Saunders Company; 1986."},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2018.01.026"},{"key":"e_1_3_3_62_2","volume-title":"Chemical-Specific Adjustment Factors for Interspecies Differences and Human Variability. IPCS Harmonization of Approaches to the Risk Assessment from the Exposure to Chemicals","author":"International Program on Chemical Safety (IPCS)","year":"2005","unstructured":"International Program on Chemical Safety (IPCS). Chemical-Specific Adjustment Factors for Interspecies Differences and Human Variability. IPCS Harmonization of Approaches to the Risk Assessment from the Exposure to Chemicals. Geneva, Switzerland: World Health Organization (WHO); 2005."},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.005"},{"key":"e_1_3_3_64_2","unstructured":"European Commission. The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation- 9th revision; 2015."},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1021\/js960496b"},{"key":"e_1_3_3_66_2","unstructured":"National Toxicology Program (NTP). NTP technical report on the photocarcinogenesis study of glycolic acid and salicylic acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 mice (simulated solar light and topical application study). NTP TR 524. NIH Publication No. 07-4472; 2007."},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13100958"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.109-1240632"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2009.04.057"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1999.tb00838.x"},{"key":"e_1_3_3_71_2","first-page":"41","article-title":"Comparative studies on the irritancy of oils and synthetic perfumes to the skin of rabbit, guina pig, rat, miniature swine and man","volume":"94","author":"Motoyoshi K","year":"1979","unstructured":"Motoyoshi K, Toyoshima Y, Sato M, Yoshimura M. Comparative studies on the irritancy of oils and synthetic perfumes to the skin of rabbit, guina pig, rat, miniature swine and man. Cosmet Toiletries. 1979;94:41-48.","journal-title":"Cosmet Toiletries"},{"key":"e_1_3_3_72_2","first-page":"53","article-title":"Screening of fragrance materials for allergenicity in the guinea pig. I. Comparison of four testing methods","volume":"28","author":"Klecak G","year":"1977","unstructured":"Klecak G, Geleick H, Frey JR. Screening of fragrance materials for allergenicity in the guinea pig. I. Comparison of four testing methods. J Soc Cosmet Chemists Jpn. 1977;28:53-64.","journal-title":"J Soc Cosmet Chemists Jpn"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1080\/105172300242526"},{"key":"e_1_3_3_74_2","unstructured":"European Chemicals Agency (ECHA). Registration evaluation authorization and restriction of chemical substances (REACH) dossier. Salicylic acid. https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/14544. Last Updated 2018. Accessed October 28 2018."},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.2007.00197.x"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(78)90009-4"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00385.x"},{"key":"e_1_3_3_78_2","first-page":"131","article-title":"Psychophysical assessment of the chemical irritability of human skin","volume":"43","author":"Green BG","year":"1992","unstructured":"Green BG, Shafffer GS. Psychophysical assessment of the chemical irritability of human skin. J Soc Cosmet Chemists Jpn. 1992;43:131-147.","journal-title":"J Soc Cosmet Chemists Jpn"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2018.01.021"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2017.05.014"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2012.08.013"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3197"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2015.01.001"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000003"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1080\/10629369408029901"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1080\/10915810591000631"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(97)00031-3"},{"key":"e_1_3_3_88_2","unstructured":"International Fragrance Association (IFRA). Code of practice standard on hexyl salicylate; 2007."},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2012.08.006"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-6264(77)80264-2"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2017.07.002"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(46)92032-6"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb02048.x"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.470204.x"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.460302.x"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2026.2002.00316.x"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000646"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2010.09090"},{"issue":"1","key":"e_1_3_3_99_2","first-page":"66","article-title":"Allergic contact dermatitis from ethylhexyl salicylate","volume":"25","author":"Miralles JC","year":"2015","unstructured":"Miralles JC, Escudero A, Carbonell A, Martinez A, Fern\u00e1ndez E, Cardona P. Allergic contact dermatitis from ethylhexyl salicylate. J Investig Allergol Clin Immunol. 2015;25(1):66-67.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_3_3_100_2","first-page":"1","article-title":"Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide\/0.1% adapalene in the acne treatment: a randomized, splkit-face, open-label, single-center study","volume":"3","author":"Zheng Y","year":"2018","unstructured":"Zheng Y, Yin S, Xia Y, et al. Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide\/0.1% adapalene in the acne treatment: a randomized, splkit-face, open-label, single-center study. Cutan Ocul Toxicol. 2018;3:1-21.","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"e_1_3_3_101_2","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.fct.2007.09.066","article-title":"A toxicologic and dermatologic assessment of salicylates when used as fragrance ingredients","volume":"45","author":"RIFM Expert Panel","year":"2007","unstructured":"RIFM Expert Panel, Belsito D, Bickers D, et al. A toxicologic and dermatologic assessment of salicylates when used as fragrance ingredients. Food Chem Toxicol. 2007;45(1S1):S318-S361.","journal-title":"Food Chem Toxicol"}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10915818251389456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10915818251389456","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10915818251389456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:23:26Z","timestamp":1777458206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10915818251389456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":100,"journal-issue":{"issue":"4_suppl","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1177\/10915818251389456"],"URL":"https:\/\/doi.org\/10.1177\/10915818251389456","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,16]]}}}